Is there an association between metabolic syndrome and cognitive function in very old adults? the newcastle 85+ study

Journal of the American Geriatrics Society

Volumn 63, Issue 4, 2015, Pages 667-675

  Harrison, Stephanie L ^a   Stephan, Blossom C M ^a   Siervo, Mario ^a   Granic, Antoneta ^a   Davies, Karen ^a   Wesnes, Keith A ^b,c   Kirkwood, Thomas B L ^a   Robinson, Louise ^a   Jagger, Carol ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Streatley on Thames   (United Kingdom)

^c NORTHUMBRIA UNIVERSITY   (United Kingdom)

Author keywords

aging; cognition; cohort study; metabolic syndrome; very old

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; ATTENTION; CHOLESTEROL BLOOD LEVEL; COGNITION; COHORT ANALYSIS; COMMUNITY LIVING; DIABETES MELLITUS; DISEASE ASSESSMENT; DISEASE ASSOCIATION; ENDOCRINE FUNCTION TEST; EPISODIC MEMORY; FEMALE; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HEART FAILURE; HOME FOR THE AGED; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NATIONAL CHOLESTEROL EDUCATION PROGRAM ADULT TREATMENT PANEL III CRITERIA; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; WAIST CIRCUMFERENCE; BLOOD; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; MEMORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY;

AGED, 80 AND OVER; ATTENTION; CHOLESTEROL, HDL; COGNITION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MEMORY; METABOLIC SYNDROME X; PROSPECTIVE STUDIES;

EID: 84928418802     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13358     Document Type: Article

References (40)

1. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive summary. Crit Pathw Cardiol 2005; 4: 198-203.
2. Panza F, Frisardi V, Seripa D, et al. Metabolic syndrome, mild cognitive impairment, and dementia. Curr Alzheimer Res 2011; 8: 492-509.
3. Vieira JR, Elkind MS, Moon YP, et al. The metabolic syndrome and cognitive performance: The Northern Manhattan Study. Neuroepidemiology 2011; 37: 153-159.
4. Schuur M, Henneman P, van Swieten JC, et al. Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol 2010; 25: 561-568.
5. Muller M, van Raamt F, Visseren FL, et al. Metabolic syndrome and cognition in patients with manifest atherosclerotic disease: The SMART study. Neuroepidemiology 2010; 34: 83-89.
6. Liu CY, Zhou HD, Xu ZQ, et al. Metabolic syndrome and cognitive impairment amongst elderly people in Chinese population: A cross-sectional study. Eur J Neurol 2009; 16: 1022-1027.
7. Viscogliosi G, Andreozzi P, Chiriac IM, et al. Screening cognition in the elderly with metabolic syndrome. Metab Syndr Relat Disord 2012; 10: 358-362.
8. van den Berg E, Biessels GJ, de Craen AJ, et al. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 2007; 69: 979-985.
9. Collerton J, Davies K, Jagger C, et al. Health and disease in 85 year olds: Baseline findings from the Newcastle 85+ cohort study. BMJ 2009; 339: b4904.
10. Davies K, Collerton JC, Jagger C, et al. Engaging the oldest old in research: Lessons from the Newcastle 85+ Study. BMC Geriatr 2010; 10: 64.
11. Davies K, Kingston A, Robinson LA, et al. Improving retention of very old participants in longitudinal research: Experiences from the Newcastle 85+ Study. PLoS One 2014; 9 (10): e108370.
12. Molloy DW, Standish TI,. A guide to the standardized Mini-Mental State Examination. Int Psychogeriatr 1997; 9 (Suppl 1): 87-94; discussion 143-150.
13. Simpson PM, Surmon DJ, Wesnes KA, et al. The cognitive drug research computerized assessment system for demented patients-a validation-study. Int J Geriatr Psychiatry 1991; 6: 95-102.
14. Wesnes KA, Ward T, McGinty A, et al. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology 2000; 152: 353-361.
15. Saxby BK, Harrington F, Wesnes KA, et al. Candesartan and cognitive decline in older patients with hypertension: A substudy of the SCOPE trial. Neurology 2008; 70: 1858-1866.
16. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Geneva, Switzerland: World Health Organization, 2011.
17. Watts AS, Loskutova N, Burns JM, et al. Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults. J Alzheimers Dis 2013; 35: 253-265.
18. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520.
19. Komulainen P, Lakka TA, Kivipelto M, et al. Metabolic syndrome and cognitive function: A population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 2007; 23: 29-34.
20. Lee KS, Eom JS, Cheong HK, et al. Effects of head circumference and metabolic syndrome on cognitive decline. Gerontology 2010; 56: 32-38.
21. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242.
22. Reijmer YD, van den Berg E, Dekker JM, et al. The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: The Hoorn Study. Atherosclerosis 2011; 219: 839-845.
23. Raffaitin C, Feart C, Le Goff M, et al. Metabolic syndrome and cognitive decline in French elders: The Three-City Study. Neurology 2011; 76: 518-525.
24. Akbaraly TN, Kivimaki M, Shipley MJ, et al. Metabolic syndrome over 10 years and cognitive functioning in late midlife: The Whitehall II study. Diabetes Care 2010; 33: 84-89.
25. Yaffe K, Weston AL, Blackwell T, et al. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009; 66: 324-328.
26. Ho RC, Niti M, Yap KB, et al. Metabolic syndrome and cognitive decline in Chinese older adults: Results from the Singapore Longitudinal Ageing Studies. Am J Geriatr Psychiatry 2008; 16: 519-522.
27. Yaffe K, Haan M, Blackwell T, et al. Metabolic syndrome and cognitive decline in elderly Latinos: Findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 2007; 55: 758-762.
28. Knopman DS, Mosley TH, Catellier DJ, et al. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study. Alzheimers Dement 2009; 5: 207-214.
29. McEvoy LK, Laughlin GA, Barrett-Connor E, et al. Metabolic syndrome and 16-year cognitive decline in community-dwelling older adults. Ann Epidemiol 2012; 22: 310-317.
30. Katsumata Y, Todoriki H, Higashiuesato Y, et al. Metabolic syndrome and cognitive decline among the oldest old in Okinawa: In search of a mechanism. The KOCOA Project. J Gerontol A Biol Sci Med Sci 2012; 67A: 126-134.
31. Xiong GL, Plassman BL, Helms MJ, et al. Vascular risk factors and cognitive decline among elderly male twins. Neurology 2006; 67: 1586-1591.
32. Liu CL, Lin MH, Peng LN, et al. Late-life metabolic syndrome prevents cognitive decline among older men aged 75 years and over: One-year prospective cohort study. J Nutr Health Aging 2013; 17: 523-526.
33. Nicholl CG, Lynch S, Kelly CA, et al. The cognitive drug research computerized assessment system in the evaluation of early dementia-is speed of the essence? Int J Geriatr Psychiatry 1995; 10: 199-206.
34. Wesnes KA,. Assessing change in cognitive function in dementia: The relative utilities of the Alzheimer's Disease Assessment Scale-Cognitive subscale and the Cognitive Drug Research System. Neurodegener Dis 2008; 5: 261-263.
35. Euser SM, van Bemmel T, Schram MT, et al. The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc 2009; 57: 1232-1237.
36. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic impact goal through 2020 and beyond. Circulation 2010; 121: 586-613.
37. Siervo M, Harrison SL, Jagger C, et al. Metabolic syndrome and longitudinal changes in cognitive function: A systematic review and meta-analysis. J Alzheimers Dis 2014; 41: 151-161.
38. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: Cardiovascular Health Study. Arch Neurol 2009; 66: 336-342.
39. Le Couteur DG, Simpson SJ,. Adaptive senectitude: The prolongevity effects of aging. J Gerontol A Biol Sci Med Sci 2011; 66A: 179-182.
40. Vischer UM, Safar ME, Safar H, et al. Cardiometabolic determinants of mortality in a geriatric population: Is there a "reverse metabolic syndrome"? Diabetes Metab 2009; 35: 108-114.